Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Surgical Science Sweden

49.20 SEK+1.91 %18/9 17:29
Less than 1K followers

SUS

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor views
Compare
+1.91 %
+31.90 %
+57.69 %
+51.85 %
+51.38 %
-44.97 %
-67.27 %
-80.48 %
+327.83 %

Surgical Science Sweden operates in the medical technology sector. The company develops VR simulators in surgery. The simulators consist of both hardware and software that are used in training and personal development for surgeons. The hardware simulates various surgical procedures, primarily used in keyhole surgery and endoscopy. The vision is to strengthen expertise in surgery and create conditions for better treatments. The headquarters are located in Gothenburg.

Read more
Market cap
2.51B SEK
Turnover
5.23M SEK
Revenue
992.34M
EBIT %
6.94 %
P/E
37.56
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Webcasts
Press releases
ShowingAll content types

Forum discussions
Pareto Securities expects a double-digit decline for surgical simulator company Surgical Science after customer Intuitive terminated its letter of intent to integrate the company’s simulation software into all da Vinci 5 (dV5) robotic systems. According to Surgical Science, this ...
11/26/2025, 7:56 AM
by timontti
7
Now there’s a spanner in the works. Intuitive is withdrawing from the memorandum of understanding drafted in January. Consequently, SUS’s simulation software will no longer be included in every delivery of the Da Vinci 5 model, but only for selected customers. As a result, next year...
11/25/2025, 11:48 PM
by Marmoset
6
This one woke up strongly today too… The effects of the Intuitive situation are turning out to be significantly smaller than anticipated. Interim report January-June 2026: Strong license revenue and improved profitability Second quarter 2026 (April–June) Net sales amounted to SEK...
8/19/2026, 9:43 AM
by Kari Kokkonen
4
Q3, perhaps a step in the right direction even though profitability is still under pressure. CMD next month. MFN – 13 Nov 25 Surgical Science Sweden AB (publ): Interim report January–Septemb... Third quarter 2025 (July – September) Net sales amounted to SEK 263.6 (231.8) million,...
11/13/2025, 7:20 AM
by sillinkutoja
3
I’m not entirely sure what opinion you ended up with on this, but at least ISRG sees some sense in it. Largest customer Intuitive Surgical will roll out its cutting-edge da Vinci 5 surgical robot in 2025e and include simulation in all systems, increasing attach rate from c30-35% ...
10/22/2025, 6:37 AM
by timontti
3
Surgical Science Sweden’s Q3’25 webcast: Inderes Surgical Science Sweden, Audiocast, Q3'25 - Inderes Time: 2025-11-13 11:00 Language: en Language: en Sector: Health care - Equipment & Services Activity: Audiocast with teleconference
11/13/2025, 1:23 PM
by Isa Hudd
2
Intuitive’s sales figures are interesting because ISRG is Surgical Science’s largest customer, and the companies have collaborated for a long time. At least as part of every Da Vinci 5 surgical robot sold by ISRG, Surgical Science’s developed simulation and training software is delivered...
10/21/2025, 10:27 PM
by Marmoset
2
Read more on our forum
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
12/11
2026

Interim report Q3'26

23/2
2027

Annual report '26

Press release2026-09-08 13:40

Redeye: Weekly Edge Case: Surgical Science

Surgical Science Sweden
Press release2026-08-20 13:19

Redeye: Surgical Science (Q2 Review): Delivering on its promises

Surgical Science Sweden
Press release2026-08-19 12:48

Redeye: Surgical Science (Q2 initial take): A reassuring quarter

Surgical Science Sweden

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Surgical Science Sweden, Audiocast, Q2'26
Webcast2026-08-19 11:00

Surgical Science Sweden, Audiocast, Q2'26

Surgical Science Sweden
Regulatory press release2026-08-19 07:30

Interim report January–June 2026: Strong license revenue and improved profitability

Surgical Science Sweden
Regulatory press release2026-08-19 07:30

Delårsrapport Januari –juni 2026: Starka licensintäkter och förbättrad lönsamhet

Surgical Science Sweden
Press release2026-08-07 09:30

Conference call regarding interim report Q2

Surgical Science Sweden
Press release2026-08-07 09:30

Telefonkonferens avseende delårsrapport Q2

Surgical Science Sweden
Regulatory press release2026-05-21 16:50

Report from the Annual General Meeting of Surgical Science Sweden AB (publ)

Surgical Science Sweden
Regulatory press release2026-05-21 16:50

Kommuniké från årsstämma i Surgical Science Sweden AB (publ)

Surgical Science Sweden
Press release2026-05-21 11:58

Redeye: Surgical Science (Q1 Review): First steps to regain confidence

Surgical Science Sweden
Surgical Science Sweden, Audiocast, Q1'26
Webcast2026-05-20 11:00

Surgical Science Sweden, Audiocast, Q1'26

Surgical Science Sweden
Regulatory press release2026-05-20 07:30

Delårsrapport januari - mars 2026: Stabil inledning på året

Surgical Science Sweden
Regulatory press release2026-05-20 07:30

Interim report January – March 2026: A solid start to the year

Surgical Science Sweden
Press release2026-05-08 09:30

Conference call regarding interim report Q1

Surgical Science Sweden
Press release2026-05-08 09:30

Telefonkonferens avseende delårsrapport Q1

Surgical Science Sweden
Regulatory press release2026-04-20 09:30

Notice of annual general meeting in SURGICAL SCIENCE SWEDEN AB (publ)

Surgical Science Sweden
Regulatory press release2026-04-20 09:30

Kallelse till årsstämma i SURGICAL SCIENCE SWEDEN AB (publ)

Surgical Science Sweden
Regulatory press release2026-04-15 11:30

Annual Report 2025

Surgical Science Sweden
Regulatory press release2026-04-15 11:30

Årsredovisning 2025

Surgical Science Sweden